FDA
-
-
-
-
-
-
-
Lee’s Pharmaceutical Announces First Patient Dosed With its Anti-PD-L1 Antibody Socazolimab, Licensed From Sorrento Therapeutics, as a First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
-
-
-
-
-
-
-
Windtree Successfully Completes Financial Restructuring Program
-
330,639 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

